Peptide Index

Master alphabetical index of all peptides in this vault.

Growth Hormone Axis

CJC-1295 NO DAC – Modified GRF(1-29), GHRH receptor agonist
CJC-1295 W DAC – DAC-modified GHRH analog, ~8-day half-life
Ghrelin – Endogenous 28-aa GHS-R1a ligand, "hunger hormone" (reference peptide)
GHRP-2 – GH Releasing Peptide-2, ghrelin mimetic
GHRP-6 – GH Releasing Peptide-6, appetite stimulant
Hexarelin – GH secretagogue with cardioprotection
IGF-1 LR3 – Long R3 IGF-1, extended activity
Ipamorelin – Selective GHS-R1a agonist, clean GH release
Macimorelin – Macrilen, oral GHS-R1a agonist, FDA-approved GHD diagnostic
MK-677 – Ibutamoren, oral GH secretagogue
PEG-MGF – Pegylated Mechano Growth Factor
Sermorelin – GHRH analog, oldest GH secretagogue
Somatostatin – Endogenous 14-aa cyclic inhibitory peptide, SSTR1-5 (reference peptide)
Tesamorelin – FDA-approved GHRH analog (Egrifta)

Recovery & Healing

BPC-157 – Body Protection Compound, gastric juice-derived healer
GHK-Cu – Copper tripeptide, 4000+ gene modulator
GHK – Tripeptide-1, copper-free variant
KPV – α-MSH fragment, NF-κB inhibitor
TB-500 – Thymosin Beta-4 fragment, actin sequestration

Weight Management & Metabolic

5-Amino-1MQ – NNMT inhibitor, NAD+ restoration
BAM15 – Small molecule mitochondrial uncoupler, energy expenditure (NOT a peptide)
Amylin – Endogenous 37-aa pancreatic peptide, co-secreted with insulin, satiety (reference peptide)
AOD-9604 – hGH fragment 177-191, lipolytic
Cagrilintide – Long-acting amylin analog, satiety-driven weight loss
CagriSema – Cagrilintide + Semaglutide combination
Dulaglutide – GLP-1/Fc fusion protein (Trulicity), FDA-approved T2D + CV risk reduction
Exenatide – Exendin-4 (Byetta/Bydureon), first-ever GLP-1 RA, venom-derived, FDA-approved
GIP – Endogenous 42-aa incretin hormone, GIPR agonist, 60-80% of incretin effect (reference peptide)
GLP-1 (Native) – Endogenous incretin hormone (reference peptide)
GLP-2 – Intestinal trophic peptide, mucosal adaptation
Liraglutide – Acylated GLP-1 agonist (Victoza/Saxenda)
Mazdutide – Dual GLP-1/glucagon receptor agonist (IBI362), approved in China for obesity
MOTS-C – Mitochondrial exercise mimetic
Orforglipron – Oral non-peptide GLP-1 RA (LY3502970), investigational small molecule
Pramlintide – Synthetic amylin analog (Symlin), FDA-approved T1D/T2D adjunct to insulin
Retatrutide – Triple-agonist (GIP/GLP-1/Glucagon)
Semaglutide – GLP-1 agonist (Ozempic/Wegovy)
Setmelanotide – Imcivree, MC4R agonist for genetic obesity (POMC/PCSK1/LEPR deficiency)
SLU-PP-332 – ERR pan-agonist, exercise mimetic
Survodutide – Dual GLP-1/glucagon receptor agonist (BI 456906), investigational for obesity + MASH
Tesofensine – Triple monoamine reuptake inhibitor (SNDRI)
Tirzepatide – GLP-1/GIP dual agonist (Mounjaro)

Anti-Aging & Longevity

Carnosine – Endogenous dipeptide (beta-Ala-His), anti-glycation, antioxidant, anti-senescence
Epitalon – Telomerase activator, pineal peptide
FOXO4-DRI – Senolytic peptide
GDF-11 – Growth Differentiation Factor 11
Glutathione – Endogenous tripeptide (Glu-Cys-Gly), master antioxidant, detoxification
Humanin – Mitochondrial-derived cytoprotective peptide
NAD+ – Dinucleotide coenzyme, cellular energy

Immune & Antimicrobial

ARA-290 – Cibinetide, EPO receptor agonist
LL-37 – Cathelicidin antimicrobial peptide
Thymosin Alpha-1 – Immune modulator (ZADAXIN)
Thymulin – Thymic peptide
Thymopentin – TP-5, thymic pentapeptide
VIP – Vasoactive Intestinal Peptide

Cognitive & Neurological

Cerebrolysin – Neurotrophic peptide mixture
Dihexa – Synaptogenesis promoter
NSI-189 – Hippocampal neurogenesis
Noopept – Nootropic dipeptide derivative
P21 – Neurogenic peptide
PE-22-88 – ADNP-derived neuroprotective
Pinealon – Neuroprotective tripeptide
Selank – Anxiolytic tuftsin analog
Semax – ACTH(4-10) analog, BDNF upregulator

Sexual Health & Hormonal

Gonadorelin – GnRH (native decapeptide)
Leuprolide – GnRH agonist (Lupron/Eligard), FDA-approved for prostate cancer, endometriosis, fibroids, precocious puberty
Goserelin – GnRH agonist (Zoladex), FDA-approved for prostate cancer, breast cancer, endometriosis
Triptorelin – GnRH agonist (Trelstar), PCT
Degarelix – GnRH antagonist peptide (Firmagon), FDA-approved for prostate cancer — no testosterone flare
Relugolix – Oral GnRH antagonist (Orgovyx/Myfembree), non-peptide small molecule, FDA-approved for prostate cancer
Elagolix – Oral GnRH antagonist (Orilissa/Oriahnn), non-peptide small molecule, FDA-approved for endometriosis, uterine fibroids
HCG – Human Chorionic Gonadotropin, LH mimetic (Pregnyl)
Kisspeptin-10 – GnRH stimulator
Melanotan 1 – Afamelanotide (SCENESSE), MC1R agonist
Melanotan II – Non-selective melanocortin agonist
Oxytocin – "Love hormone"
PT-141 – Bremelanotide (Vyleesi), sexual health

Bone & Endocrine

Teriparatide – PTH(1-34) (Forteo), FDA-approved anabolic osteoporosis therapy
Calcitonin – Salmon calcitonin (Miacalcin/Fortical), FDA-approved antiresorptive + analgesic
Desmopressin – DDAVP/Stimate/Nocdurna, synthetic vasopressin analog, V2-selective
Setmelanotide – Imcivree, selective MC4R agonist for genetic obesity (also in Metabolic)
Macimorelin – Macrilen, oral GHS-R1a agonist for GHD diagnosis (also in GH Axis)

Mitochondrial

MOTS-C – Exercise mimetic, AMPK activator
SS-31 – Elamipretide, cardiolipin stabilizer
Humanin – Cytoprotective MDP
NAD+ – Cellular energy restoration

Sleep

DSIP – Delta Sleep-Inducing Peptide
Epitalon – Melatonin restoration

Cosmetic / Topical

Argireline – Botox-like topical (Acetyl Hexapeptide-3)
GHK-Cu – Copper peptide for skin
GHK – Tripeptide-1
Matrixyl – Palmitoyl Pentapeptide-4
SNAP-8 – Acetyl Octapeptide-3, elongated Argireline with enhanced SNARE inhibition
Syn-ake – Snake venom mimetic

Khavinson Bioregulators

Short peptides (2-4 amino acids) from the Khavinson bioregulation school (Institute of Bioregulation and Gerontology, St. Petersburg). Proposed to regulate tissue-specific gene expression via chromatin remodeling and DNA interaction. >95% of evidence from a single research group; independent Western validation is lacking.

Vilon — Thymic dipeptide (Lys-Glu), immune support, anti-aging
Crystagen — Thymic tripeptide (Glu-Asp-Pro), T-cell immunity
Chonluten — Bronchial/GI tripeptide (Glu-Asp-Gly), mucosal support
Cartalax — Cartilage tripeptide (Ala-Glu-Asp), joint/bone support
Pinealon — Pineal tripeptide (Glu-Asp-Arg), neuroprotection
Cortagen — Cortex tetrapeptide (Ala-Glu-Asp-Pro), neuroprotection
Cardiogen — Cardiac tetrapeptide (Ala-Glu-Asp-Arg), cardiovascular
Livagen — Hepatic tetrapeptide (Lys-Glu-Ala-Ser), liver support
Pancragen — Pancreatic tetrapeptide (Lys-Glu-Asp-Trp), metabolic
Testagen — Testicular tetrapeptide (Lys-Glu-Asp-Gly), reproductive
Prostamax — Prostatic tetrapeptide (Lys-Glu-Asp-Pro), prostate support

Blends & Stacks

GLOW Blend – GHK-Cu + BPC-157 + TB-500
KLOW Blend – GHK-Cu + BPC-157 + TB-500 + KPV
Wolverine Stack – BPC-157 + TB-500 (± PEG-MGF)
Tesamorelin-Ipamorelin Blend – GHRH + GHRS combo

Gastrointestinal

Linaclotide – Linzess®, GC-C agonist, FDA-approved (2012) for IBS-C and CIC
Plecanatide – Trulance®, uroguanylin analog GC-C agonist, FDA-approved (2017) for IBS-C and CIC

Pain & Analgesic

Difelikefalin – Korsuva®, peripheral kappa-opioid receptor agonist, FDA-approved (2021) for CKD-aP
Ziconotide – Prialt®, cone snail venom-derived N-type calcium channel blocker, FDA-approved (2004) for severe chronic pain

Cancer Therapeutic

PNC-27 – Chimeric p53-penetratin peptide, selective cancer cell membranolysis via membrane HDM-2
PNC-28 – p53(17-26)-penetratin chimera, anticancer necrotic peptide with in vivo data

Follistatin

Follistatin 344 – Myostatin inhibitor, muscle growth

Somatostatin Analogs & PRRT

Octreotide – Sandostatin®, SSTR2/SSTR5 agonist, FDA-approved (1988) for acromegaly, carcinoid, VIPomas
Lanreotide – Somatuline Depot®, SSTR2-selective, FDA-approved (2007) for acromegaly and GEP-NETs (CLARINET trial)
Pasireotide – Signifor®, pan-SSTR (SSTR5-preferring), FDA-approved (2012) for Cushing's disease, (2014) acromegaly
Lutetium-177-DOTATATE – Lutathera®, radiolabeled PRRT, FDA-approved (2018) for SSTR+ GEP-NETs (NETTER-1/2 trials)
Lutetium-177-PSMA-617 – Pluvicto®, PSMA-targeted radioligand, FDA-approved (2022) for PSMA+ mCRPC (VISION trial)

FDA-Approved Peptides

Calcitonin – Miacalcin®/Fortical® (osteoporosis, Paget's disease, hypercalcemia)
Desmopressin – DDAVP®/Stimate®/Nocdurna® (diabetes insipidus, enuresis, hemophilia A, vWD)
Difelikefalin – Korsuva® (CKD-associated pruritus in hemodialysis, 2021)
HCG – Pregnyl®/Novarel® (hypogonadism, ovulation induction)
Lanreotide – Somatuline Depot® (acromegaly, GEP-NETs)
Linaclotide – Linzess® (IBS-C, chronic idiopathic constipation, 2012)
Liraglutide – Victoza®/Saxenda® (T2D/obesity)
Lutetium-177-DOTATATE – Lutathera® (SSTR+ GEP-NETs)
Lutetium-177-PSMA-617 – Pluvicto® (PSMA+ mCRPC)
Macimorelin – Macrilen® (diagnosis of adult GH deficiency)
Melanotan 1 – SCENESSE® (EPP)
Octreotide – Sandostatin® (acromegaly, carcinoid, VIPomas)
Oxytocin – Pitocin® (labor)
Pasireotide – Signifor® (Cushing's disease, acromegaly)
Plecanatide – Trulance® (CIC, IBS-C, 2017)
PT-141 – Vyleesi® (HSDD)
Semaglutide – Ozempic®/Wegovy® (T2D/obesity)
Setmelanotide – Imcivree® (genetic obesity: POMC/PCSK1/LEPR deficiency)
SS-31 – FORZINITY™ (Barth Syndrome)
Teriparatide – Forteo® (osteoporosis, glucocorticoid-induced osteoporosis)
Tesamorelin – Egrifta® (HIV lipodystrophy)
Tirzepatide – Mounjaro®/Zepbound® (T2D/obesity)
Ziconotide – Prialt® (severe chronic pain, intrathecal, 2004)

Related MOCs

#MOC #index #peptides